CELF2 and neoplasm: Combined with the indispensable role of DCs in anti‐tumour immunity and the promising future of DC vaccines in tumour treatment, we are confident that clarifying the mechanism by which CELF2 interacts with DCs in the TME may provide a new target for immunotherapy.46, 47, 48